European Heart Journal Supplements

Article	Citations
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies	69
Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review	44
Long COVID: long-term effects?	35
What do we do about atrial high rate episodes?	30
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation	25
Left ventricular unloading and the role of ECpella	24
Atrial fibrillation in low- and middle-income countries: a narrative review	23
Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites	23
Lipoprotein(a) and PCSK9 inhibition: clinical evidence	21
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal	19
Coagulopathy and COVID-19	19
Atrial fibrillation: villain or bystander in vascular brain injury	18
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations	17
Infective endocarditis and neurologic events: indications and timing for surgical interventions	16
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction	16
Escalation and de-escalation of mechanical circulatory support in cardiogenic shock	14
Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease	14
HEART VALVE DISEASESP1 SEX AND GENDER DIFFERENCES IN TAVI PATIENTS: FROM CLINICAL PRESENTATION TO PROCEDURAL OUTCOMES	14
Sympathetic activation in heart failure	14
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications	13
Stroke prevention in atrial fibrillation: comparison of recent international guidelines	13
Post-procedural radial artery occlusion and patency detection using duplex ultrasound vs. the reverse Barbeau test	13
COVID-19: patients with stroke or risk of stroke	13
What can health systems learn from COVID-19?	12
Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation	12

The omics of channelopathies and cardiomyopathies: what we know and how they are useful	12
The impact of COVID-19 and COVID vaccination on cardiovascular outcomes	11
Influenza and cardiovascular disease pathophysiology: strings attached	11
May Measurement Month 2019: results of blood pressure screening from 47 countries	11
The metaverse in medicine	11
Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: new risk factors, concepts and controversies	11
Beyond cardiovascular medicine: potential future uses of icosapent ethyl	10
Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine	10
Severe aortic stenosis in the young, with or without bicuspid valve: is transcatheter aortic valve implantation the first choice?	10
ANMCO POSITION PAPER: Role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock	10
Is physical activity always good for you? The physical activity paradox	9
Current and future use of neuromodulation in heart failure	9
Differential effects of inotropes and inodilators on renal function in acute cardiac care	9
Aortic and mitral bioprosthetic valve dysfunction: surgical or percutaneous solutions?	9
Myths to debunk: the non-compacted myocardium	9
Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy	9
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis	9
Time is brain: timing of revascularization of brain arteries in stroke	9
Stress Echo 2030: the new ABCDE protocol defining the future of cardiac imaging	9
Advanced remote care for heart failure in times of COVID-19 using an implantable pulmonary artery pressure sensor: the new normal	9
Intensive care unit management of percutaneous mechanical circulatory supported patients: the role of imaging	8
Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies	8
The value and limitations of new oral anticoagulant plasma level assessments	8
52nd ANMCO Congress Abstracts e-Posters	8
Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging	8
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines	7
Renal arteries denervation with second generation systems: a remedy for resistant hypertension?	7
The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature	7
Impact of the COVID-19 pandemic: a perspective from industry	7
Weaning from Impella and mobilization of Impella patients	7
The treatment of amyloidosis is being refined	7
Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure	7
Electrical storm management in structural heart disease	7
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)	7
May Measurement Month 2018: an analysis of blood pressure screening results from China	7
Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia	7
The path of transcatheter aortic valve implantation: from compassionate to low-risk cases	7
Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap	7
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?	7
Mechanisms of action, efficacy, and safety of icosapent ethyl: from bench to bedside	7
Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes	7
Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction	7
The ‘dreaded PFO’: anatomical and functional features of high risk for stroke	7
Scarring/arrhythmogenic cardiomyopathy	7
The natural history of hypertrophic cardiomyopathy	6
Mitral valve prolapse with ventricular arrhythmias: does it carries a worse prognosis?	6
Left bundle branch area pacing results in more physiological ventricular activation than biventricular pacing in patients with left bundle branch block heart failure	6
Myocardial infarction and viral triggers: what do we know by now?	6
May Measurement Month 2018: an analysis of blood pressure screening results from Spain	6
Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation	6

May Measurement Month 2018: an analysis of blood pressure screening results from Ghana	6
Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation	6
Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease	6
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran	6
The management of non-culprit coronary lesions in patients with acute coronary syndrome	6
Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR	6
May Measurement Month 2019: an analysis of blood pressure screening results from Cameroon	6
Early risk of mortality, cardiovascular events, and bleeding in patients with newly diagnosed atrial fibrillation	6
Neuromodulation devices for heart failure	6
Acute rate control in atrial fibrillation: an urgent need for the clinician	5
Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants	5
Echocardiography strain: why is it used more and more?	5
ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes	5
Short-term treatments for acute cardiac care: inotropes and inodilators	5
Does sacubitril/valsartan work in acute myocardial infarction? The PARADISE-AMI study	5
Optimized patient selection in high-risk protected percutaneous coronary intervention	5
Sodium-glucose co-transporter 2 inhibitors in heart failure: an updated evidence-based practical guidance for clinicians	5
P292 REDEFINING THE EPIDEMIOLOGY OF CARDIAC AMYLOIDOSIS. A SYSTEMATIC REVIEW OF SCREENING STUDIES	5
Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention	5
Sodium–glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome	5
Evolution of interventional imaging in structural heart disease	5
The Brugada syndrome: pharmacological therapy	5
How effective is cryoablation in the treatment of atrial fibrillation?	5
Clinical impact of myocardial fibrosis in severe aortic stenosis	5
Thrombosis in pre- and post-vaccination phase of COVID-19	5
Managing vascular access and closure for percutaneous mechanical circulatory support	5
May Measurement Month 2018: an analysis of blood pressure screening results from Nepal	5
Concepts in cardiac oncology	5
Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease	4
Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome	4
Getting ahead of the game: in-hospital initiation of HFrEF therapies	4
May Measurement Month 2019: an analysis of blood pressure screening results from Spain	4
Focus on arrhythmogenic right ventricular cardiomyopathy	4
Treatment of amyloidosis: present and future	4
May Measurement Month 2018: an analysis of blood pressure screening results from Malaysia	4
May Measurement Month 2019: an analysis of blood pressure screening results from Hungary	4
Patient with heart failure: importance to treat valvular diseases	4
May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland	4
May Measurement Month 2018: an analysis of blood pressure screening in the Philippines	4
Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions	4
Is there a relationship between blood pressure values and dementia?	4
Trends beyond the new normal: from remote monitoring to digital connectivity	4
Clinical implications of cardiac magnetic resonance imaging fibrosis	4
May Measurement Month 2018: results of blood pressure screening from 41 countries	4
Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?	4
P311 TAKOTSUBO CARDIOMYOPATHY RELATED TO MRNA SARS–COV2 VACCINE	4
The new type 2 diabetes mellitus therapy: comparison between the two classes of drugs GLPR (glucagon-like peptide receptor) agonists and SGLT2 (sodium–glucose cotransporter 2) inhibitors	4
Left atrial appendage occlusion in COVID-19 times	4
Patient with valvular disease: evolving care patterns	4
Pump flow setting and assessment of unloading in clinical practice	4
The journey of omega-3 fatty acids in cardiovascular medicine	4
Atrial fibrillation in advanced renal failure: are there alternative solutions to warfarin-dicumarol?	4
Ablation of ventricular tachycardia in 2021	4
Chronic heart failure: the role of di vericiguat	4
What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?	4
Update on supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease according to the LIRA method	4
Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics	4
COVID-19 and paediatric patient involvement (cardiovascular aspects)	4
May Measurement Month 2018: an analysis of blood pressure screening results from Vietnam	4
ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation	4
ARRHYTHMIAS, PACING, ABLATIONC1 A DEPENDENT SYNCOPE	4
Takotsubo syndrome: more frequent in women, more dangerous in men	4
ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis	4
Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials	4
May Measurement Month 2018: an analysis of blood pressure screening results from Australia	4
May Measurement Month 2019: an analysis of blood pressure screening results from Saudi Arabia	4
Cardiac complications of COVID-19 vaccination: now we know more	4
Can QRS morphology be used to differentiate between true septal vs. apparently septal lead placement? An analysis of ECG of real mid-septal, apparent mid-septal, and apical pacing	4
The myocardial bridge: incidence, diagnosis, and prognosis of a pathology of uncertain clinical significance	4
The importance of adherence and persistence in the elderly atrial fibrillation patient	4
Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures	3
Advanced heart failure: from definitions to therapeutic options	3
May Measurement Month 2018: an analysis of blood pressure screening results from Italy	3
Pacing of the specialized His–Purkinje conduction system: ‘back to the future’	3
Chronic ischaemic heart disease and rivaroxaban: which patients derive the greatest benefit?	3
May Measurement Month 2018: an analysis of blood pressure screening results from Republic of the Congo	3
Influenza vaccination in patients affected by diabetes	3
May Measurement Month 2019: an analysis of blood pressure screening results from Korea	3
May Measurement Month 2019: an analysis of blood pressure screening results from Kenya	3
Causes of sudden death	3

May Measurement Month 2018: an analysis of blood pressure screening results from Indonesia	3
May Measurement Month 2018: an analysis of blood pressure screening results from Sudan	3
May Measurement Month 2019: an analysis of blood pressure screening results from Nepal	3
Prevention of chemotherapy-induced left ventricular dysfunction	3
Cardiac magnetic resonance-guided cardiac ablation: a case series of an early experience	3
New prevention scenarios: polygenic risk	3
Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe	3
May Measurement Month 2019: an analysis of blood pressure screening results from Mexico	3
Acute coronary syndromes: hospital management of dyslipidaemia with proprotein convertase subtilisin/kexin 9 inhibitors: time to act	3
544 Two cases of constrictive pericarditis temporally associated with mRNA-1273 COVID-19 vaccination	3
Electrocardiogram in arrhytmogenic cardiomyopathy	3
May Measurement Month 2019: an analysis of blood pressure screening results from Nigeria	3
Is drinking wine in moderation good for health or not?	3
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy	3
Intravascular haemolysis after transcatheter aortic valve implantation with self-expandable prosthesis: incidence, severity, and impact on long-term mortality	3
May Measurement Month 2019: an analysis of blood pressure screening results from Australia	3
When Brugada syndrome is at risk of sudden death: clinical and anatomical aspects	3
May Measurement Month 2018: an analysis of blood pressure screening results from United Arab Emirates	3
The role of cardiologists on the stroke unit	3
May Measurement Month 2019: an analysis of blood pressure screening results from Slovenia	3
May Measurement Month 2018: an analysis of blood pressure screening results from Mexico	3
Cardiovascular prevention: Mediterranean or low-fat diet?	3
The electrocardiogram in non-ischaemic-dilated cardiomyopathy	3
Challenges in ischaemic heart disease: not sleeping enough, not brushing your teeth, and skipping breakfast—three ways of increasing your risk of myocardial infarction?	3
Therapy of Type 2 diabetes: more gliflozines and less metformin?	3
The impact of the COVID-19 pandemic upon patients, staff, and on the future practices of percutaneous coronary intervention	3
The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?	3
The link between influenza and myocardial infarction: vaccination protects	3
Representation matters: a call for inclusivity and equity in heart failure clinical trials	3
Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease	3
May Measurement Month 2019: an analysis of blood pressure screening results from Lebanon	3
Autopsy and sudden death	3
Blood pressure screening results from May Measurement Month 2019 in Vietnam	3
Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy	3
Less sodium and more potassium to reduce cardiovascular risk	3
May Measurement Month 2019: an analysis of blood pressure screening results from Ghana-Sub-Saharan Africa	3
Cardioprotective shock management: monitoring and supportive therapies	3
The value of the 12-lead electrocardiogram in the prediction of sudden cardiac death	3
What connection is there between intestinal microbiota and heart disease?	3
Implantable ventricular assistance systems (VAD) as a bridge to transplant or as ‘destination therapy’	3
Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction	3
May Measurement Month 2018: an analysis of blood pressure screening results from Albania	3
Renal arteries denervation: from the treatment of resistant hypertension to the treatment of atrial fibrillation	3
Analysis of blood pressure and selected cardiovascular risk factors in the Democratic Republic of the Congo: the May Measurement Month 2018 results	3
New and old echographic parameters in heart failure	3
Recurrent pericarditis is less scary: the new therapeutic solutions	3
May Measurement Month 2019: an analysis of blood pressure screening results from Italy	3
‘Use of lipid-lowering therapy: the guidelines, the drugs or the patient?’	2
ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure	2
May Measurement Month 2018: an analysis of blood pressure screening campaign results in India	2
Pre-hospital delay, clinical characteristics, angiographic findings, and in-hospital mortality in young and middle-aged adults with acute coronary syndrome: a single-centre registry analysis	2
Present and future of coronary risk assessment	2
Monitoring MCS patients on the intensive care unit: integrating haemodynamic assessment, laboratory data, and imaging techniques for timely detection of deterioration and recovery	2
Computed tomography to replace invasive coronary angiography? The DISCHARGE trial	2
May Measurement Month 2018: an analysis of blood pressure screening results from Nigeria	2
Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible	2
Association between heart and dementia… keep an eye on the left atrium	2
Procedures for chronic total occlusion: when are they recommended and when not	2
54 Sacubitril–valsartan (LCZ 696) improves longitudinal strain and ejection fraction in preclinical models treated with doxorubicin through NLRP3, MyD88, and pro-fibrotic chemokines	2
Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid	2
May Measurement Month 2019: an analysis of blood pressure screening results from Cape Verde	2
Clinical results and mechanism of action of icosapent ethyl	2
End-stage heart failure patients should be treated instantly despite a pandemic with all-time available technology to ensure best outcomes	2
May Measurement Month 2019: an analysis of blood pressure screening results from South Africa	2
May Measurement Month 2018: blood pressure screening results in Cameroon	2
May Measurement Month 2019: an analysis of blood pressure screening results from Republic of the Congo	2
Treatment in patients with severe asymptomatic aortic stenosis: is it best not to wait?	2
The new in anticoagulation: factor XI inhibitors	2
Transcatheter ablation in patients with Brugada syndrome	2
Defining the optimal revascularization strategy during protected high-risk procedures with Impella	2
P280 TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE–CHALLENGE OF DOUBLE ANTI–HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES	2
May Measurement Month 2018: an analysis of blood pressure screening results from Angola	2
Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis	2
New interventional solutions in calcific coronary atherosclerosis: drill, laser, shock waves	2
P357 THE MANAGEMENT OF CHOLESTEROL LEVEL CONTROL WITH LIPID–LOWERING DRUGS IN ITALIAN CLINICAL PRACTICE: FINDINGS FROM THE STREAM (SUPPORTING WITH THE REAL–WORLD EVIDENCE THE ASSESSMENT OF MEDICINES A	2
Ventricular fibrillation ablation in cardiomyopathies and arrhythmic storm	2
May Measurement Month 2019: an analysis of blood pressure screening results from Angola	2
May Measurement Month 2019: an analysis of blood pressure screening results from Malawi	2
308 Sex-related differences in long COVID-19 syndrome	2
Dilemmas in cardiology: when to recanalize a chronic total occlusion	2
Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?	2
May Measurement Month 2018: an analyses of blood pressure screening results from Cabo Verde	2
Old unsolved problems: when and how to treat silent ischaemia	2
Optimal bail-out and complication management strategies in protected high-risk percutaneous coronary intervention with the Impella	2
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with advanced chronic kidney and liver diseases	2
Heart failure therapy: the fifth card	2
What is known in pre-, peri-, and post-procedural anticoagulation in micro-axial flow pump protected percutaneous coronary intervention?	2
May Measurement Month 2019: an analysis of blood pressure screening results from the Democratic Republic of the Congo	2
C90 PRE–EXISTING CORONARY ARTERY DISEASE AMONG COVID–19 PATIENTS: A SYSTEMATIC REVIEW AND META–ANALYSIS	2
The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation	2
May Measurement Month 2019: an analysis of blood pressure screening results from Colombia	2
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy	2
P149 AN UNUSUAL CASE OF CARDIAC TAMPONADE AND ST–SEGMENT ELEVATION MYOCARDIAL INFARCTION	2
May Measurement Month 2019: an analysis of blood pressure screening results from Zambia	2
P73 ANGIOGRAPHY–DERIVED INDEX OF MICROVASCULAR RESISTANCE (IMR–ANGIO) IN TAKOTSUBO SYNDROME	2